Genelux Corporation
GNLX
Cena:
$ 2.92
0.00 (0.00%)
Valuace
70
Růst
0
Zdraví
50
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| WOODWARD DIVERSIFIED CAPITAL, LLC | 2.1 mil | 5.69% | -1.17% | 2.69% | 2023-09-30 |
| VANGUARD GROUP INC | 1.6 mil | 4.09% | 0.00% | 0.00% | 2023-03-31 |
| BLEICHROEDER LP | 1.4 mil | 3.71% | 0.03% | 0.58% | 2025-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 453.76 tis | 1.22% | 0.00% | 0.00% | 2023-03-31 |
| BLACKROCK, INC. | 405.87 tis | 1.09% | 0.00% | 0.00% | 2024-09-30 |
| BANK OF AMERICA CORP /DE/ | 323.87 tis | 0.87% | 0.00% | 0.00% | 2023-06-30 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 280.90 tis | 0.76% | -0.01% | 0.01% | 2025-06-30 |
| ALYESKA INVESTMENT GROUP, L.P. | 285.00 tis | 0.75% | 0.00% | 0.00% | 2025-03-31 |
| HEIGHTS CAPITAL MANAGEMENT, INC | 238.37 tis | 0.68% | 0.30% | 0.30% | 2025-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 251.61 tis | 0.68% | 0.00% | 0.00% | 2026-03-31 |
| CM MANAGEMENT, LLC | 250.00 tis | 0.67% | 0.51% | 0.51% | 2026-03-31 |
| GLOBAL RETIREMENT PARTNERS, LLC | 217.09 tis | 0.57% | 0.00% | 0.02% | 2025-06-30 |
| NORTHERN TRUST CORP | 164.46 tis | 0.44% | 0.00% | 0.00% | 2023-03-31 |
| PROVIDENT WEALTH MANAGEMENT, LLC | 155.67 tis | 0.42% | -0.09% | 0.11% | 2023-09-30 |
| STATE STREET CORP | 145.85 tis | 0.39% | 0.00% | 0.00% | 2023-03-31 |
| LPL FINANCIAL LLC | 139.04 tis | 0.37% | 0.00% | 0.00% | 2023-09-30 |
| MARSHALL WACE, LLP | 139.15 tis | 0.37% | 0.00% | 0.00% | 2024-03-31 |
| UBS GROUP AG | 122.58 tis | 0.33% | 0.00% | 0.00% | 2023-03-31 |
| DAUNTLESS INVESTMENT GROUP, LLC | 123.19 tis | 0.32% | 0.46% | 0.46% | 2025-06-30 |
| ADVISOR GROUP HOLDINGS, INC. | 119.01 tis | 0.32% | 0.00% | 0.00% | 2023-03-31 |
| LIFESTEPS FINANCIAL, INC. | 118.86 tis | 0.32% | -0.15% | 0.18% | 2023-06-30 |
| MILLENNIUM MANAGEMENT LLC | 104.40 tis | 0.28% | 0.00% | 0.00% | 2023-12-31 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 92.80 tis | 0.24% | 0.00% | 0.00% | 2024-06-30 |
| MORGAN STANLEY | 88.05 tis | 0.24% | 0.00% | 0.00% | 2023-03-31 |
| AMG NATIONAL TRUST BANK | 75.35 tis | 0.20% | 0.00% | 0.00% | 2023-09-30 |
| FALCON WEALTH PLANNING | 63.19 tis | 0.17% | -0.01% | 0.01% | 2023-09-30 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 61.98 tis | 0.17% | 0.00% | 0.00% | 2024-06-30 |
| STEEL PEAK WEALTH MANAGEMENT LLC | 60.90 tis | 0.16% | 0.00% | 0.00% | 2023-09-30 |
| 683 CAPITAL MANAGEMENT, LLC | 60.00 tis | 0.16% | -0.02% | 0.01% | 2025-12-31 |
| SQUAREPOINT OPS LLC | 58.57 tis | 0.15% | 0.00% | 0.00% | 2024-06-30 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 54.63 tis | 0.14% | 0.00% | 0.00% | 2025-12-31 |
| PALOMA PARTNERS MANAGEMENT CO | 50.00 tis | 0.14% | 0.02% | 0.02% | 2025-03-31 |
| CREATIVE PLANNING | 45.57 tis | 0.12% | 0.00% | 0.00% | 2024-12-31 |
| MIRACLE MILE ADVISORS, LLC | 40.00 tis | 0.11% | 0.00% | 0.00% | 2024-06-30 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 41.00 tis | 0.11% | 0.00% | 0.00% | 2025-12-31 |
| POINT72 ASSET MANAGEMENT, L.P. | 39.56 tis | 0.10% | 0.00% | 0.00% | 2025-12-31 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 37.74 tis | 0.10% | 0.00% | 0.00% | 2025-12-31 |
| EXCHANGE TRADED CONCEPTS, LLC | 34.15 tis | 0.10% | 0.00% | 0.00% | 2023-06-30 |
| 33.33 tis | 0.09% | -0.05% | 0.07% | 2025-12-31 | |
| BARCLAYS PLC | 32.76 tis | 0.09% | 0.00% | 0.00% | 2025-12-31 |
| GOLDMAN SACHS GROUP INC | 32.61 tis | 0.09% | 0.00% | 0.00% | 2025-03-31 |
| ENVESTNET ASSET MANAGEMENT INC | 29.99 tis | 0.09% | 0.00% | 0.00% | 2025-03-31 |
| PVG ASSET MANAGEMENT CORP | 29.15 tis | 0.08% | 0.34% | 0.34% | 2025-03-31 |
| ONE CAPITAL MANAGEMENT, LLC | 30.88 tis | 0.08% | 0.00% | 0.00% | 2023-09-30 |
| RAYMOND JAMES FINANCIAL INC | 30.76 tis | 0.08% | 0.00% | 0.00% | 2024-12-31 |
| MARINER, LLC | 27.87 tis | 0.08% | 0.00% | 0.00% | 2026-03-31 |
| MAI CAPITAL MANAGEMENT | 25.88 tis | 0.07% | 0.00% | 0.00% | 2024-12-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 25.00 tis | 0.07% | 0.00% | 0.00% | 2025-03-31 |
| TWO SIGMA INVESTMENTS, LP | 24.99 tis | 0.07% | 0.00% | 0.00% | 2024-06-30 |
| KWB WEALTH | 23.33 tis | 0.06% | 0.00% | 0.01% | 2023-12-31 |
| XTX TOPCO LTD | 22.94 tis | 0.06% | 0.00% | 0.00% | 2025-12-31 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 22.71 tis | 0.06% | 0.00% | 0.00% | 2024-06-30 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | 22.56 tis | 0.06% | 0.00% | 0.00% | 2025-12-31 |
| CATALYST FUNDS MANAGEMENT PTY LTD | 21.82 tis | 0.06% | 0.01% | 0.01% | 2026-03-31 |
| KEEL POINT, LLC | 20.50 tis | 0.06% | 0.00% | 0.00% | 2025-03-31 |
| D.A. DAVIDSON & CO. | 21.78 tis | 0.06% | 0.00% | 0.00% | 2024-12-31 |
| BALYASNY ASSET MANAGEMENT L.P. | 21.47 tis | 0.06% | 0.00% | 0.00% | 2025-12-31 |
| AMERICAN CENTURY COMPANIES INC | 18.84 tis | 0.05% | 0.00% | 0.00% | 2025-03-31 |
| 5T WEALTH, LLC | 19.70 tis | 0.05% | -0.01% | 0.02% | 2025-03-31 |
| CITADEL ADVISORS LLC | 19.42 tis | 0.05% | 0.00% | 0.00% | 2024-03-31 |
| MAN GROUP PLC | 16.66 tis | 0.05% | 0.00% | 0.00% | 2024-09-30 |
| AXXCESS WEALTH MANAGEMENT, LLC | 16.67 tis | 0.05% | 0.00% | 0.00% | 2023-03-31 |
| APOLLON WEALTH MANAGEMENT, LLC | 18.78 tis | 0.05% | 0.00% | 0.00% | 2023-12-31 |
| BEACON CAPITAL MANAGEMENT, LLC | 19.12 tis | 0.05% | 0.00% | 0.01% | 2024-12-31 |
| OMERS ADMINISTRATION CORP | 17.60 tis | 0.05% | 0.00% | 0.00% | 2025-12-31 |
| NINE MASTS CAPITAL LTD | 17.47 tis | 0.05% | 0.01% | 0.01% | 2026-03-31 |
| COMMONWEALTH EQUITY SERVICES, LLC | 17.08 tis | 0.05% | 0.00% | 0.00% | 2024-06-30 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 14.99 tis | 0.05% | 0.00% | 0.01% | 2024-06-30 |
| LIBERTY WEALTH MANAGEMENT LLC | 16.55 tis | 0.04% | 0.00% | 0.01% | 2025-03-31 |
| VANGUARD GLOBAL ADVISERS, LLC | 16.01 tis | 0.04% | 0.00% | 0.00% | 2026-03-31 |
| CLARITY CAPITAL PARTNERS LLC | 14.88 tis | 0.04% | -0.01% | 0.02% | 2023-12-31 |
| SG AMERICAS SECURITIES, LLC | 14.69 tis | 0.04% | 0.00% | 0.00% | 2025-03-31 |
| BROWN BROTHERS HARRIMAN & CO | 14.45 tis | 0.04% | 0.00% | 0.00% | 2023-09-30 |
| BROKERS INTERNATIONAL FINANCIAL SERVICES, LLC. | 15.05 tis | 0.04% | 0.00% | 0.00% | 2025-03-31 |
| ADVISOR RESOURCE COUNCIL | 12.67 tis | 0.04% | 0.00% | 0.00% | 2025-03-31 |
| HRT FINANCIAL LP | 13.45 tis | 0.04% | 0.00% | 0.00% | 2026-03-31 |
| STRATOS WEALTH PARTNERS, LTD. | 12.75 tis | 0.03% | 0.00% | 0.00% | 2024-09-30 |
| ATRIA INVESTMENTS, INC | 11.74 tis | 0.03% | 0.00% | 0.00% | 2025-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 12.20 tis | 0.03% | 0.00% | 0.00% | 2024-03-31 |
| DIAMETRIC CAPITAL, LP | 12.15 tis | 0.03% | 0.01% | 0.01% | 2026-03-31 |
| UNITED BANK | 12.07 tis | 0.03% | 0.00% | 0.00% | 2025-06-30 |
| JANE STREET GROUP, LLC | 12.00 tis | 0.03% | 0.00% | 0.00% | 2026-03-31 |
| VIRTU FINANCIAL LLC | 10.45 tis | 0.03% | 0.00% | 0.00% | 2024-12-31 |
| PRIVATE MANAGEMENT GROUP INC | 11.33 tis | 0.03% | 0.00% | 0.00% | 2025-06-30 |
| MERCER GLOBAL ADVISORS INC /ADV | 10.75 tis | 0.03% | 0.00% | 0.00% | 2025-03-31 |
| RONALD BLUE TRUST, INC. | 10.17 tis | 0.03% | 0.00% | 0.00% | 2023-12-31 |
| CENTAURUS FINANCIAL, INC. | 10.00 tis | 0.03% | 0.00% | 0.00% | 2024-12-31 |
| PLANCORP, LLC | 10.01 tis | 0.03% | 0.00% | 0.00% | 2024-03-31 |
| WHITTIER TRUST CO OF NEVADA INC | 7.14 tis | 0.02% | 0.00% | 0.00% | 2023-12-31 |
| ROYAL BANK OF CANADA | 6.14 tis | 0.02% | 0.00% | 0.00% | 2023-03-31 |
| WELLS FARGO & COMPANY/MN | 4.49 tis | 0.01% | 0.00% | 0.00% | 2023-03-31 |
| BNP PARIBAS ARBITRAGE, SNC | 4.45 tis | 0.01% | 0.00% | 0.00% | 2024-12-31 |
| COPPELL ADVISORY SOLUTIONS LLC | 3.00 tis | 0.01% | 0.00% | 0.00% | 2024-06-30 |
| FMR LLC | 1.47 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| ALLWORTH FINANCIAL LP | 0.16 tis | 0.00% | 0.00% | 0.00% | 2023-03-31 |
| CLEARSTEAD ADVISORS, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| POINT72 (DIFC) LTD | 0.00 tis | 0.00% | 0.00% | 0.00% | 2024-06-30 |
| CITIGROUP INC | 0.01 tis | 0.00% | 0.00% | 0.00% | 2023-03-31 |
| AFFINITY ASSET ADVISORS, LLC | 0.00 tis | 0.00% | -0.03% | 0.00% | 2024-06-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Smalling Ralph | officer: Head of Regulatory | S-Sale | 270 | 2.98 | 12.5 2026 | 67803 |
| Zindrick Thomas | officer: President and CEO | S-Sale | 2798 | 2.94 | 12.5 2026 | 532051 |
| Cappello Joseph | officer: Chief Technical Officer | S-Sale | 605 | 2.97 | 12.5 2026 | 154549 |
| Yu Yong | officer: Chief Scientific Officer | S-Sale | 605 | 2.97 | 12.5 2026 | 149706 |
| Zindrick Thomas | officer: President and CEO | S-Sale | 3582 | 2.42 | 26.3 2026 | 534849 |
| Yu Yong | officer: SVP, Clinical Development | S-Sale | 906 | 2.42 | 26.3 2026 | 144938 |
| Cappello Joseph | officer: Chief Technical Officer | S-Sale | 906 | 2.42 | 26.3 2026 | 155154 |
| Smalling Ralph | officer: Head of Regulatory | S-Sale | 240 | 2.51 | 26.3 2026 | 68073 |
| Smalling Ralph | officer: Head of Regulatory | S-Sale | 345 | 2.42 | 26.3 2026 | 68313 |
| Thomas John | director | S-Sale | 10000 | 2.90 | 3.3 2026 | 482784 |
| Litten Jason | officer | 0 | 0.00 | 7.1 2026 | 0 | |
| Litten Jason | officer: Chief Medical Officer | A-Award | 275000 | 4.55 | 7.1 2026 | 275000 |
| Cappello Joseph | officer: Chief Technical Officer | S-Sale | 973 | 5.37 | 11.12 2025 | 156060 |
| Cappello Joseph | officer: Chief Technical Officer | S-Sale | 1463 | 3.36 | 11.12 2025 | 157033 |
| Cappello Joseph | officer: Chief Technical Officer | S-Sale | 1270 | 3.33 | 11.12 2025 | 158496 |
| Zindrick Thomas | officer: President and CEO | S-Sale | 4509 | 5.37 | 11.12 2025 | 538431 |
| Zindrick Thomas | officer: President and CEO | S-Sale | 12673 | 3.33 | 11.12 2025 | 542940 |
| Yu Yong | officer: SVP, Clinical Development | S-Sale | 973 | 5.37 | 11.12 2025 | 145844 |
| Yu Yong | officer: SVP, Clinical Development | S-Sale | 3219 | 3.36 | 11.12 2025 | 146817 |
| Smalling Ralph | officer: Head of Regulatory | S-Sale | 165 | 4.69 | 9.12 2025 | 68658 |
| Smalling Ralph | officer: Head of Regulatory | S-Sale | 343 | 5.37 | 9.12 2025 | 68823 |
| Smalling Ralph | officer: Head of Regulatory | S-Sale | 580 | 3.36 | 9.12 2025 | 69166 |
| Smalling Ralph | officer: Head of Regulatory | S-Sale | 1244 | 3.36 | 9.12 2025 | 69746 |
| Thomas John | director | S-Sale | 10000 | 5.00 | 2.12 2025 | 492784 |
| Cappello Joseph | officer: Chief Technical Officer | D-Return | 13333 | 6.00 | 3.9 2025 | 0 |
| Cappello Joseph | officer: Chief Technical Officer | D-Return | 65000 | 22.40 | 3.9 2025 | 0 |
| Cappello Joseph | officer: Chief Technical Officer | A-Award | 13333 | 3.33 | 3.9 2025 | 13333 |
| Cappello Joseph | officer: Chief Technical Officer | A-Award | 16666 | 3.33 | 3.9 2025 | 16666 |
| Cappello Joseph | officer: Chief Technical Officer | A-Award | 65000 | 3.33 | 3.9 2025 | 65000 |
| Cappello Joseph | officer: Chief Technical Officer | A-Award | 80000 | 3.33 | 3.9 2025 | 80000 |
| Smalling Ralph | officer: Head of Regulatory | D-Return | 8333 | 6.00 | 3.9 2025 | 0 |
| Smalling Ralph | officer: Head of Regulatory | A-Award | 8333 | 3.33 | 3.9 2025 | 8333 |
| Smalling Ralph | officer: Head of Regulatory | A-Award | 10000 | 0.00 | 3.9 2025 | 70990 |
| Yu Yong | officer: SVP, Clinical Development | D-Return | 207652 | 6.00 | 3.9 2025 | 0 |
| Yu Yong | officer: SVP, Clinical Development | D-Return | 65000 | 22.40 | 3.9 2025 | 0 |
| Yu Yong | officer: SVP, Clinical Development | A-Award | 65000 | 3.33 | 3.9 2025 | 65000 |
| Yu Yong | officer: SVP, Clinical Development | A-Award | 207652 | 3.33 | 3.9 2025 | 207652 |
| Zindrick Thomas | director, officer: President and CEO | D-Return | 250000 | 22.40 | 3.9 2025 | 0 |
| Zindrick Thomas | director, officer: President and CEO | D-Return | 23568 | 6.00 | 3.9 2025 | 0 |
| Zindrick Thomas | director, officer: President and CEO | A-Award | 23568 | 3.33 | 3.9 2025 | 23568 |
| Zindrick Thomas | director, officer: President and CEO | A-Award | 157372 | 3.33 | 3.9 2025 | 157372 |
| Zindrick Thomas | director, officer: President and CEO | A-Award | 250000 | 3.33 | 3.9 2025 | 250000 |
| Zindrick Thomas | director, officer: President and CEO | A-Award | 925000 | 3.33 | 3.9 2025 | 925000 |
| Cappello Joseph | officer: Chief Technical Officer | A-Award | 142500 | 3.64 | 29.8 2025 | 142500 |
| Cappello Joseph | officer: Chief Technical Officer | A-Award | 107500 | 0.00 | 29.8 2025 | 159766 |
| Tyree James L | director | A-Award | 28576 | 3.64 | 29.8 2025 | 28576 |
| Tyree James L | director | A-Award | 22283 | 0.00 | 29.8 2025 | 68074 |
| Mirabelli Mary | director | A-Award | 28576 | 3.64 | 29.8 2025 | 28576 |
| Mirabelli Mary | director | A-Award | 22283 | 0.00 | 29.8 2025 | 73284 |
| Yu Yong | officer: SVP, Clinical Development | A-Award | 134520 | 3.64 | 29.8 2025 | 134520 |
| Yu Yong | officer: SVP, Clinical Development | A-Award | 101480 | 0.00 | 29.8 2025 | 150036 |
| Smither John W | director | A-Award | 28576 | 3.64 | 29.8 2025 | 28576 |
| Smither John W | director | A-Award | 22283 | 0.00 | 29.8 2025 | 74994 |
| Smalling Ralph | officer: Head of Regulatory | A-Award | 34770 | 3.64 | 29.8 2025 | 34770 |
| Smalling Ralph | officer: Head of Regulatory | A-Award | 26230 | 0.00 | 29.8 2025 | 60990 |
| Zindrick Thomas | officer: President and CEO | A-Award | 478800 | 3.64 | 29.8 2025 | 478800 |
| Zindrick Thomas | officer: President and CEO | A-Award | 361200 | 0.00 | 29.8 2025 | 554161 |
| Thomas John | director | A-Award | 28576 | 3.64 | 29.8 2025 | 28576 |
| Thomas John | director | A-Award | 22283 | 0.00 | 29.8 2025 | 502784 |
| Groen Eric | 0 | 0.00 | 2.7 2025 | 0 | ||
| Groen Eric | officer: General Counsel & Secretary | A-Award | 270000 | 2.83 | 2.7 2025 | 270000 |
| Thomas John | director | G-Gift | 25000 | 0.00 | 24.6 2025 | 480501 |
| Smalling Ralph | officer: Head of Regulatory | S-Sale | 1259 | 2.92 | 13.5 2025 | 34760 |
| Cappello Joseph | officer: VP, Pharmaceutical Development | S-Sale | 4737 | 2.92 | 13.5 2025 | 52266 |
| Yu Yong | officer: VP, Clinical Trial Operations | S-Sale | 5579 | 2.92 | 13.5 2025 | 47640 |
| Zindrick Thomas | director, officer: President and CEO | S-Sale | 10764 | 2.92 | 13.5 2025 | 191447 |
| Ryder Sean | officer: General Counsel | S-Sale | 4475 | 2.92 | 13.5 2025 | 47621 |
| Zindrick Thomas | director, officer: President and CEO | A-Award | 30339 | 0.00 | 17.4 2025 | 202211 |
| Ryder Sean | officer: General Counsel | A-Award | 10708 | 0.00 | 17.4 2025 | 52096 |
| Yu Yong | officer: VP, Clinical Trial Operations | A-Award | 13350 | 0.00 | 17.4 2025 | 53219 |
| Cappello Joseph | officer: VP, Pharmaceutical Development | A-Award | 13350 | 0.00 | 17.4 2025 | 57003 |
| Smalling Ralph | officer: Head of Regulatory | A-Award | 4172 | 0.00 | 17.4 2025 | 36019 |
| Pulisic Matthew | 0 | 0.00 | 3.2 2025 | 0 | ||
| Pulisic Matthew | officer: Chief Financial Officer | A-Award | 275000 | 3.95 | 3.2 2025 | 275000 |
| Tyree James L | director | A-Award | 50469 | 1.96 | 31.12 2024 | 50469 |
| Smither John W | director | A-Award | 50469 | 1.96 | 31.12 2024 | 50469 |
| Mirabelli Mary | director | A-Award | 50469 | 1.96 | 31.12 2024 | 50469 |
| Thomas John | director | A-Award | 50469 | 1.96 | 31.12 2024 | 50469 |
| Tyree James L | director | S-Sale | 3460 | 2.46 | 30.12 2024 | 45791 |
| Zindrick Thomas | director, officer: President and CEO | A-Award | 134500 | 0.00 | 20.12 2024 | 171872 |
| Zindrick Thomas | director, officer: President and CEO | A-Award | 183000 | 2.29 | 20.12 2024 | 183000 |
| Zak Lourie S. | officer: Chief Financial Officer | A-Award | 56525 | 2.29 | 20.12 2024 | 56525 |
| Zak Lourie S. | officer: Chief Financial Officer | A-Award | 41650 | 0.00 | 20.12 2024 | 82452 |
| Cappello Joseph | officer: VP, Pharmaceutical Development | A-Award | 39000 | 2.29 | 20.12 2024 | 39000 |
| Cappello Joseph | officer: VP, Pharmaceutical Development | A-Award | 29000 | 0.00 | 20.12 2024 | 43653 |
| Yu Yong | officer: VP, Clinical Trial Operations | A-Award | 39000 | 2.29 | 20.12 2024 | 39000 |
| Yu Yong | officer: VP, Clinical Trial Operations | A-Award | 29000 | 0.00 | 20.12 2024 | 39869 |
| Ryder Sean | officer: General Counsel | A-Award | 30000 | 2.29 | 20.12 2024 | 30000 |
| Ryder Sean | officer: General Counsel | A-Award | 22000 | 0.00 | 20.12 2024 | 41388 |
| Smalling Ralph | officer: Head of Regulatory | A-Award | 21100 | 2.29 | 20.12 2024 | 21100 |
| Smalling Ralph | officer: Head of Regulatory | A-Award | 15525 | 0.00 | 20.12 2024 | 31847 |
| Cappello Joseph | officer: VP, Pharmaceutical Development | S-Sale | 6300 | 2.34 | 18.12 2024 | 14653 |
| Smalling Ralph | officer: Head of Regulatory | S-Sale | 2510 | 2.34 | 18.12 2024 | 16322 |
| Zak Lourie S. | officer: Chief Financial Officer | S-Sale | 2103 | 2.34 | 18.12 2024 | 40802 |
| Zindrick Thomas | director, officer: President and CEO | S-Sale | 14315 | 2.34 | 18.12 2024 | 37372 |
| Scigalla Paul | officer: Chief Medical Officer | A-Award | 16666 | 6.00 | 21.10 2024 | 16666 |
| Tyree James L | 0 | 0.00 | 26.9 2024 | 0 | ||
| Szalay Aladar | 10 percent owner | S-Sale | 33080 | 2.57 | 13.9 2024 | 599821 |
| Szalay Aladar | 10 percent owner | S-Sale | 31777 | 2.73 | 13.9 2024 | 632901 |
| Tyree James L | director | S-Sale | 1730 | 2.60 | 12.9 2024 | 47521 |
